Drugs / Ariely
last change Feb 2026 re-read 2 minutes ago

Ariely

Developed for
non-small cell lung carcinoma
Investigated by
Jiangsu Province Nanjing Brain Hospital

Trials 1 · a red edge is where a trial was stopped

20252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT06332300 Feb 2024 → Feb 2025 non-small cell lung carcinoma Jiangsu Province Nanjing Brain Hospital Withdrawn No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Ariely ClinicalTrials.gov intervention name — accepted as the source's own label NCT06332300